Výsledky vyhledávání - "D, Hunninghake"

Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group

Autor: C A, Dujovne, R, Knopp, P, Kwiterovich, D, Hunninghake, T A, McBride, M, Poland

Publikováno v: Mayo Clinic proceedings. 75(11)

To determine the relative efficacy and safety of cerivastatin and pravastatin in patients with type II hypercholesterolemia.In this prospective, double-blind, parallel-group study, hypercholesterolemic patients were randomized to treatment with ceriv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::addcb73d1123974ac02afde74cfbe1e0
https://pubmed.ncbi.nlm.nih.gov/11075741

Zobrazit plný text záznamu

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators

Autor: M, Miller, R, Byington, D, Hunninghake, B, Pitt, C D, Furberg

Publikováno v: Archives of internal medicine. 160(3)

The efficacy of lipid-lowering therapy (LLT) has been well established for patients with preexisting coronary artery disease (CAD). However, limited information is available assessing the extent to which these medications are prescribed in academic m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f3bf0281a6f76dbd97569b9529808ea9
https://pubmed.ncbi.nlm.nih.gov/10999996

Zobrazit plný text záznamu

Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease

Autor: D, Hunninghake, R G, Bakker-Arkema, J P, Wigand, M, Drehobl, H, Schrott, J L, Early, P, Abdallah, S, McBride, D M, Black

Publikováno v: The Journal of family practice. 47(5)

Our study compared use of atorvastatin, fluvastatin, lovastatin, and simvastatin for lowering low-density lipoprotein (LDL) cholesterol concentration in patients at risk for coronary heart disease (CHD). The goal was to reach the LDL cholesterol leve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fb3cf16f7b84edca93897ac891710954
https://pubmed.ncbi.nlm.nih.gov/9834769

Zobrazit plný text záznamu

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Autor: P, Jones, S, Kafonek, I, Laurora, D, Hunninghake

Publikováno v: The American journal of cardiology. 81(5)

The objective of this multicenter, randomized, open-label, parallel-group, 8-week study was to evaluate the comparative dose efficacy of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor atorvastatin 10, 20, 40, and 80 mg compar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f6f4e630d353b0963f41492cc4dfe377
https://pubmed.ncbi.nlm.nih.gov/11327075

Zobrazit plný text záznamu

Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia

Autor: W, Insull, D, Black, C, Dujovne, J D, Hosking, D, Hunninghake, L, Keilson, R, Knopp, J, McKenney, E, Stein, A J, Troendle

Publikováno v: Archives of internal medicine. 154(21)

Fluvastatin sodium is a new, entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor that may be an effective lipid-lowering agent in patients whose hyperlipidemia does not respond to dietary therapy. We conducted a study to eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::85e47e2f4a33730ae0c8373708c9d34b
https://pubmed.ncbi.nlm.nih.gov/7979841

Zobrazit plný text záznamu

Determination of apolipoprotein E genotypes by single-strand conformational polymorphism

Autor: M Y, Tsai, P, Suess, K, Schwichtenberg, J H, Eckfeldt, J, Yuan, M, Tuchman, D, Hunninghake

Publikováno v: Clinical chemistry. 39(10)

We used single-strand conformational polymorphism (SSCP) to determine apolipoprotein E (Apo E) genotypes in 47 individuals. A 295-base-pair (bp) DNA fragment coding for amino acid residues 80-178 of the Apo E protein gave distinct patterns for the th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5d0f26d7b7ec00d6babde6ef36d30f3b
https://pubmed.ncbi.nlm.nih.gov/8403396

Zobrazit plný text záznamu

LDL-cholesterol as a determinant of coronary heart disease

Autor: D, Hunninghake

Publikováno v: Clinical therapeutics. 12(5)

The Adult Treatment Panel of the National Cholesterol Education Program identified high levels of LDL-cholesterol as a major risk factor in developing CHD and as the primary target for cholesterol-lowering therapy. Low levels of HDL were recognized a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7738de2ca3cb9445d8ba3f1a2297deef
https://pubmed.ncbi.nlm.nih.gov/2268861

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání